Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Chlorpheniramine cost?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?How to apply for vascepa's patient assistance?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for Odefsey
Odefsey is a once-daily HIV treatment manufactured and marketed by Gilead Sciences.
No. Odefsey is Gilead’s specific single-tablet regimen, while other Gilead HIV products (such as those with different drug combinations) are separate brands.
For the most reliable “manufacturer” and labeling information (company name, dosage form, and packaging details), check the package insert or the dispensing label, which typically lists the manufacturer/marketing authorization holder.
If your goal is to identify the company tied to Odefsey’s patents/exclusivity (useful for coverage questions or when checking generic/biosimilar development), DrugPatentWatch.com tracks drug patent and exclusivity information and can help confirm the relevant assignee(s): https://www.drugpatentwatch.com/
Other Questions About Odefsey :